Abstract
Psychiatric medication is an important tool in helping us provide more effective treatment for people with serious mental illness. It is important to remember that medication is only a tool, not a goal. A treatment plan should never have a primary focus of getting the person take medication as ordered. Rather, treatment starts with understanding the person’s own life goals, what problems get in the way of these goals, and how medication can be a tool to help the person better deal with these problems. This dialogue does not start with diagnosis or a symptom list, but rather starts with understanding what the person wants and needs to improve their life, be it a job or an apartment or a relationship or a used car. We need to focus on problems that get in the way of these goals and how the effective use of medication can better help the person achieve his or her own goals.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Copeland, M.E. (1997) Wellness Recovery Action Plan. Peach Press.
Center for Public Service Psychiatry (2021) Collaborative medication management and discontinuation assistance. Community Psychiatry Forum Video Seminar Series; Available at https://www.cpsp.pitt.edu/videoconferences-2020-2021/. Accessed on 2/26/2022
Cramer, J.A. & Rosenheck, R (1998) Compliance with medication regimens for mental and physical disorder. Psychiatr Serv, 49, 196–201.
Deegan, P.E. & Drake, R.E. (2006) Shared decision-making and medication management in the recovery process. Psychiatr Serv, 57, 11.
Deegan, P.E. (2005) The importance of personal medicine: A qualitative study of resilience in people with psychiatric disabilities. J Public Health, 33, 29–35
Diamond, R.J. & Scheifler, P.L. (2007) Treatment Collaboration: Improving the Therapist, Prescriber, Client Relationship. New York: WW Norton.
Diamond, R. (2008) Engaging the crisis patient around medication. In (Eds) Glick, R.L., Berlin, J.S., Fishkind, A., & Zeller, S. Emergency Psychiatry: Principles and Practice. Philidelphia: Lippincott Williams & Wilkins.
Dobber J et al (2018) Medication adherence in patients with schizophrenia: a qualitative study of the patient process in motivational interviewing. BMC Psychiatry 18: 135: 1274–9
Fenton, W.S., Blyler, C.R., Heinssen, R.K. (1997) Determinants of medication compliance in schizophrenia: Empirical and clinical findings. Schizophre Bull, 23, 637–651.
Gilmer, T.P., Dolder, C.R., Lacro, J.P., Folsom, D.P., Lindamer, L., Garcia, P., and Jeste, D.V. (2004) Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. Am J Psychiatry, 161, 692–699.
Groot, PC., van Os. (2020). How user knowledge of psychotropic drug withdrawal resulted in the development of person-specific tapering medication. Therapeutic Advances in Psychopharmacology. 2000. 10, 1–13
Kaar S.J. et al. (2019) Making decisions about antipsychotics. a qualitative study of patient experiences and the development of a decision aid. BMC Psychiatry 19(1): 309
Lacro, J.P., Dunn, L.B., Dolder, C.R., Leckband, S.G., Jeste, D.V. (2002) Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literature. J Clin Psychiat, 63, 892–909.
Lang, K., Meyers, J.L., Korn, J.R., Lee, S., Sikirica, M., Crivera, C., Dirani, R., Menzin, J. (2010) Medication adherence and hospitalization among patients with schizophrenia treated with antipsychotics. Psychiatr Serv, 61, 1239–47.
Livingston, M (2012) Guide to when and how to safely withdraw antipsychotics. Prescriber. 23, 37–40.
Mann, D.M., Woodward, M., Muntner, P., Falzon, L., Kronish, I. (2010) Predictors of nonadherence to statins: A systematic review and meta-analysis. Ann Pharmacother. 44, 1410–21. Epub 2010 Aug 11.
Miller, W.R. & Rollnick, S. (2002) Motivational Interviewing: Preparing People for Change. New York: Guilford Press
New York State Office of Mental Health. (2017) Talking to patients and their families about Clozapine. Available https://www.thenationalcouncil.org/wp-content/uploads/2017/03/Talking-to-patients-and-their-families-about-Clozapine.pdf?daf+375ateTbd56 Accessed 05 January 2022.
Olivares J.M. et al.. (2009) Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: results from the Electronic schizophrenia Treatment Adherence Registry (eSTAR). Eur Psychiatry June, 24(5): 287–96
Rosenheck, R.A. et al. (2011) Long-acting risperidone and oral antipsychotics in unstable schizophrenia, N Eng J Med Mar 31; 364(13): 1281
Shrank, W.H. & Avorn, J. (2007) Educating patients about their medications: The potential and limitations of written drug information. Health Affairs, 26, 731–740.
Sowers W, Golden S (1999) Psychotropic medication management in persons with co-occurring psychiatric and substance use disorders. Journal of Psychoactive Drugs. January-March 31(1): 59–70.
Steiner J.F. and Earnest M.A. (2001) Lingua Medica: The Language of Medication-Taking. Ann Intern Med 132; 132: 926–930
Subotnik, K.L et al. (2015) Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrnie. A Randomized Clinical Trial. JAMA Psychiatry Aug 72(8) 822–9
Velligan, D.I., Weiden, P.J., Sajotovic, M., Scott, J., Carpenter, D., Ross, R., & Docherty, J.P. (2010) Assessment of adherence problems in patients with serious and persistent mental illness: Recommendations from the expert consensus guidelines. J of Psychiatric Prac, 16, 32–45.
Wright, J.H., Turkington, D., Kingdon, D.G., & Basco, M.R. (2009) Cognitive-Behavior Therapy for Severe Mental Illness: An Illustrated Guide. Washington, DC: American Psychiatric Publishers, Inc.
Yang, Y., Thumula, V., Pace, P.F., Banahan, B.F. 3rd, Wilkin, N.E., Lobb, W.B. (2009) Predictors of medication non-adherence among patients with diabetes in Medicare Part D programs: A retrospective cohort study. Clin Ther., 31, 2178–88; discussion 2150-1.
Acknowledgement
My appreciation to Jon Berlin, Mark Ragins, Alan Rosen, David Katzelnick, and Cher Diamond for their comments on drafts of this chapter.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Diamond, R.J., Sowers, W.E. (2022). Collaborative Medication Management and Discontinuation. In: Sowers, W.E., McQuistion, H.L., Ranz, J.M., Feldman, J.M., Runnels, P.S. (eds) Textbook of Community Psychiatry. Springer, Cham. https://doi.org/10.1007/978-3-031-10239-4_15
Download citation
DOI: https://doi.org/10.1007/978-3-031-10239-4_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-10238-7
Online ISBN: 978-3-031-10239-4
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)